Cardiac Structure and Function in Patients with Cystic Fibrosis
Condition(s) studied
Study summary
In a prospective observational cohort study (n = 100), the investigators aim to assess the correlation between cardiac biomarkers, advanced echocardiography and cystic fibrosis genotype and severity and determine whether these are prognostic markers of heart disease in patients suffering from cystic fibrosis (CF).
Eligibility
Primary outcome measure(s)
- Rate of cardiovascular mortality — 2, 5 and 10 year follow-up
- Incidence of myocardial infarction — 2, 5 and 10 year follow-up
- Incidence of coronary revascularization (percutaneous coronary intervention/coronary artery bypass graft) — 2, 5 and 10 year follow-up
- Incidence of heart failure — 2, 5 and 10 year follow-up
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen | Hellerup | Copenhagen | |
| Department of Infectious Diseases, University Hospital of Copenhagen, Cystic Fibrosis Centre, Copenhagen, Denmark | Copenhagen | Denmark |
More Herlev and Gentofte Hospital trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06084468 on ClinicalTrials.gov ↗ ← All trials in Denmark